Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Immaculate Nankya

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
AIDS Research and Therapy|January 24, 2019
First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in UgandaArt F Y Poon, Emmanuel Ndashimye, Mariano Avino, et al.
Journal of the International Association of Providers of AIDS Care|October 10, 2013
Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African WomenTracy L Lemonovich, Richard R Watkins, Charles S Morrison, et al.
AIDS (London, England)|June 4, 2013
Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study periodFred Kyeyune, Immaculate Nankya, Samar Metha, et al.
Journal of Virology|January 18, 2008
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replicationYong Gao, Michael A Lobritz, Justin Roth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 4, 2014
Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assayAndrew F Longosz, Charles S Morrison, Pai-Lien Chen, et al.
AIDS Research and Human Retroviruses|October 16, 2014
Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and DAndrew F Longosz, Charles S Morrison, Pai-Lien Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2011
Hormonal contraceptive use and HIV disease progression among women in Uganda and ZimbabweCharles S Morrison, Pai-Lien Chen, Immaculate Nankya, et al.
AIDS Research and Human Retroviruses|January 23, 2018
Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Fred Kyeyune, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2021
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutationsEmmanuel Ndashimye, Yue Li, Paul S Reyes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen FailureFred Kyeyune, Richard M Gibson, Immaculate Nankya, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
AIDS Research and Therapy|January 24, 2019
First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in UgandaArt F Y Poon, Emmanuel Ndashimye, Mariano Avino, et al.
Journal of the International Association of Providers of AIDS Care|October 10, 2013
Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African WomenTracy L Lemonovich, Richard R Watkins, Charles S Morrison, et al.
AIDS (London, England)|June 4, 2013
Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study periodFred Kyeyune, Immaculate Nankya, Samar Metha, et al.
Journal of Virology|January 18, 2008
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replicationYong Gao, Michael A Lobritz, Justin Roth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 4, 2014
Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assayAndrew F Longosz, Charles S Morrison, Pai-Lien Chen, et al.
AIDS Research and Human Retroviruses|October 16, 2014
Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and DAndrew F Longosz, Charles S Morrison, Pai-Lien Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2011
Hormonal contraceptive use and HIV disease progression among women in Uganda and ZimbabweCharles S Morrison, Pai-Lien Chen, Immaculate Nankya, et al.
AIDS Research and Human Retroviruses|January 23, 2018
Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Fred Kyeyune, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2021
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutationsEmmanuel Ndashimye, Yue Li, Paul S Reyes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen FailureFred Kyeyune, Richard M Gibson, Immaculate Nankya, et al.
Pageof 4